5051 - 5060 of 8587 Results
Title
Year
-
OPENTitle: Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 112Issue #:Start Page: 136End Page: 148Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2018.01.004Best OA location URL: https://repositorio.uchile.cl/handle/2250/167345Citation Count: 145
-
OPENTitle: Longitudinal intronic RNA-Seq analysis of Parkinson’s disease patients reveals disease-specific nascent transcriptionJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 247Issue #: 11Start Page: 945End Page: 957Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702221081027Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/15353702221081027Citation Count: 8
-
OPENTitle: Machine learning nominates the inositol pathway and novel genes in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 3Start Page: 887End Page: 899Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad345Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad345/51927901/awad345.pdfCitation Count: 18
-
OPENTitle: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansionJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 699Issue #:Start Page: 134End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6443492Citation Count: 9
-
RESTRICTEDTitle: Divalent metal ions control activity and inhibition of protein kinasesJournal Name: MetallomicsPublisher: Oxford University Press (OUP)Vol: 9Issue #: 11Start Page: 1576End Page: 1584Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c7mt00204aCitation Count: 52
-
OPENTitle: LRRK2 variation and Parkinson's disease in African AmericansJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1973End Page: 1976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23163Best OA location URL: https://europepmc.org/articles/pmc2939165?pdf=renderCitation Count: 13
-
OPENTitle: A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 11Issue #: 4Start Page: e0153564End Page: e0153564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0153564Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0153564&type=printableCitation Count: 5
-
OPENTitle: α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathologyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0532-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0532-8Citation Count: 33
- Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants2024RESTRICTEDTitle: Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 126Issue #:Start Page: 107041End Page: 107041Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107041Citation Count: 0
-
OPENTitle: Quantitative 3D histochemistry reveals region-specific amyloid-β reduction by the antidiabetic drug netoglitazoneJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 20Issue #: 5Start Page: e0309489End Page: e0309489Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0309489Best OA location URL: https://doi.org/10.1371/journal.pone.0309489Citation Count: 0